Association of Increased Frequencies of HLA-DPB1*05:01 with the Presence of Anti-Ro/SS-A and Anti-La/SS-B Antibodies in Japanese Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Furukawa, Hiroshi ^a   Oka, Shomi ^a   Shimada, Kota ^b   Sugii, Shoji ^b   Hashimoto, Atsushi ^a   Komiya, Akiko ^a   Fukui, Naoshi ^a   Nagai, Tatsuo ^c   Hirohata, Shunsei ^c   Setoguchi, Keigo ^d   Okamoto, Akira ^e   Chiba, Noriyuki ^f   Suematsu, Eiichi ^a   Miyashita, Taiichiro ^g   Migita, Kiyoshi ^g   Suda, Akiko ^h   Nagaoka, Shouhei ^h   Tsuchiya, Naoyuki ⁱ   Tohma, Shigeto ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION HIMEJI MEDICAL CENTER   (Japan)

^f Japan   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^h Yokohama Minami Kyosai Hospital   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; LA ANTIBODY; RO ANTIBODY;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC ASSOCIATION STUDIES; HLA-DP BETA-CHAINS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 84872183951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053910     Document Type: Article

References (30)

1. Perricone C, Ceccarelli F, Valesini G (2011) An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev 10: 599-608. Epub 2011 Apr 2022.
2. Scott IC, Steer S, Lewis CM, Cope AP, (2011) Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis. Best Pract Res Clin Rheumatol 25: 447-468.
3. Lewis SN, Nsoesie E, Weeks C, Qiao D, Zhang L (2011) Prediction of disease and phenotype associations from genome-wide association studies. PLoS ONE 6: e27175. Epub 22011 Nov 27174.
4. Reveille JD, (1998) The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 10: 187-200.
5. Hernandez-Molina G, Leal-Alegre G, Michel-Peregrina M, (2010) The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome. Autoimmun Rev 10: 123-125.
6. Rischmueller M, Lester S, Chen Z, Champion G, Van Den Berg R, et al. (1998) HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS). Clin Exp Immunol 111: 365-371.
7. Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, et al. (2003) In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 48: 2240-2245.
8. Tzioufas AG, Wassmuth R, Dafni UG, Guialis A, Haga HJ, et al. (2002) Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjogren's syndrome (pSS): a European multicentre study. Ann Rheum Dis 61: 398-404.
9. Miyagawa S, Shinohara K, Nakajima M, Kidoguchi K, Fujita T, et al. (1998) Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum 41: 927-934.
10. Schneeberger E, Citera G, Heredia M, Maldonado Cocco J, (2008) Clinical significance of anti-Ro antibodies in rheumatoid arthritis. Clin Rheumatol 27: 517-519.
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
12. Hochberg M, (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
13. Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, et al. (2010) New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren's syndrome. Clin Exp Immunol 162: 53-61.
14. Furukawa H, Oka S, Shimada K, Sugii S, Ohashi J, et al. (2012) Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: A protective role for shared epitope. PLoS ONE 7: e33133.
15. Oka S, Furukawa H, Kashiwase K, Tsuchiya N, Tohma S, (2012) Identification of a novel HLA allele, HLA-DQB1*06:51, in a Japanese rheumatoid arthritis patient. Tissue Antigens 80: 386-387.
16. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41: 591-595.
17. Noguchi E, Sakamoto H, Hirota T, Ochiai K, Imoto Y, et al. (2011) Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet 7: e1002170.
18. Kominami S, Tanabe N, Ota M, Naruse TK, Katsuyama Y, et al. (2009) HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis. J Hum Genet 54: 108-114.
19. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, et al. (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44: 291-296.
20. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, et al. (2012) Genetically distinct subsets within ANCA-Associated Vasculitis. N Engl J Med 367: 214-223.
21. Boire G, Menard HA, (1988) Clinical significance of anti-Ro(SSA) antibody in rheumatoid arthritis. J Rheumatol 15: 391-394.
22. Boire G, Menard HA, Gendron M, Lussier A, Myhal D, (1993) Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster. J Rheumatol 20: 1654-1660.
23. Tishler M, Moutsopoulos HM, Yaron M, (1992) Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis. J Rheumatol 19: 234-236.
24. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, et al. (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368: 711-718.
25. Tishler M, Golbrut B, Shoenfeld Y, Yaron M, (1994) Anti-Ro(SSA) antibodies in patients with rheumatoid arthritis-a possible marker for gold induced side effects. J Rheumatol 21: 1040-1042.
26. Tishler M, Nyman J, Wahren M, Yaron M, (1997) Anti-Ro (SSA) antibodies in rheumatoid arthritis patients with gold-induced side effects. Rheumatol Int 17: 133-135.
27. Kamada N, Kinoshita K, Togawa Y, Kobayashi T, Matsubara H, et al. (2006) Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro/SS-A and a review of the published work. J Dermatol 33: 616-622.
28. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, et al. (2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428: 486.
29. McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperaviciute D, et al. (2011) HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 364: 1134-1143.
30. Furukawa H, Oka S, Shimada K, Rheumatoid Arthritis-Interstitial Lung Disease Study Consortium, Tsuchiya N, et al. (2012) HLA-A*31:01 and methotrexate-induced interstitial lung aisease in Japanese rheumatoid arthritis patients: A multi-drug hypersensitivity marker? Ann Rheum Dis in press.